Maze Therapeutics Inc (MAZE)
$31.48 -1.41% Close Oct 30, 2026 Live
Maze Therapeutics stock today
Maze Therapeutics closed at $31.48 on October 30, 2026, down 1.41% on the day. Over the past year it returned -5.2% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.74 billion.
$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | MAZE | S&P 500 (SPY) |
|---|---|---|
| 1 month | +15.8% | -0.9% |
| 3 months | +13.9% | +2.1% |
| Year to date | -24.0% | +11.7% |
| 1 year | -5.2% | +12.4% |
Key statistics
- Market value
- $1.74B
- Price / sales
- 87.1
- 52-week range
- $22.39 to $51.84
- Next report
- Nov 5, 2026 (estimated)
About Maze Therapeutics
Biopharmaceutical company developing treatments based on genetic disease insights.
Sector: Health Care
More on Maze Therapeutics
- Returns: what $1,000 became$1,000 one year ago is $947.62 today
No forecast, no recommendation. This page describes Maze Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.